286 related articles for article (PubMed ID: 28629718)
1. Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors.
Kim EY; Roshanravan H; Dryer SE
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2342-2354. PubMed ID: 28629718
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms underlying modulation of podocyte TRPC6 channels by suPAR: Role of NADPH oxidases and Src family tyrosine kinases.
Kim EY; Hassanzadeh Khayyat N; Dryer SE
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3527-3536. PubMed ID: 30293571
[TBL] [Abstract][Full Text] [Related]
3. Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin Activation.
Staeck O; Slowinski T; Lieker I; Wu K; Rudolph B; Schmidt D; Brakemeier S; Neumayer HH; Wei C; Reiser J; Budde K; Halleck F; Khadzhynov D
Transplantation; 2015 Dec; 99(12):2593-7. PubMed ID: 26371597
[TBL] [Abstract][Full Text] [Related]
4. RAGE and αVβ3-integrin are essential for suPAR signaling in podocytes.
Kim EY; Dryer SE
Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166186. PubMed ID: 34166766
[TBL] [Abstract][Full Text] [Related]
5. TRPC6 and FSGS: the latest TRP channelopathy.
Mukerji N; Damodaran TV; Winn MP
Biochim Biophys Acta; 2007 Aug; 1772(8):859-68. PubMed ID: 17459670
[TBL] [Abstract][Full Text] [Related]
6. Opposing effects of podocin on the gating of podocyte TRPC6 channels evoked by membrane stretch or diacylglycerol.
Anderson M; Kim EY; Hagmann H; Benzing T; Dryer SE
Am J Physiol Cell Physiol; 2013 Aug; 305(3):C276-89. PubMed ID: 23657570
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis.
Chung CF; Kitzler T; Kachurina N; Pessina K; Babayeva S; Bitzan M; Kaskel F; Colmegna I; Alachkar N; Goodyer P; Cybulsky AV; Torban E
PLoS One; 2019; 14(5):e0216426. PubMed ID: 31095586
[TBL] [Abstract][Full Text] [Related]
8. A novel gain-of-function mutation in transient receptor potential C6 that causes podocytes injury.
Yu M; Hu J; Ju T; Wang R; Wang M; Gao C; Xia Z
Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):284-288. PubMed ID: 38814201
[TBL] [Abstract][Full Text] [Related]
9. suPAR and chronic kidney disease-a podocyte story.
Zeier M; Reiser J
Pflugers Arch; 2017 Aug; 469(7-8):1017-1020. PubMed ID: 28689240
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic signaling evoked by tumor necrosis factor in podocytes.
Abkhezr M; Kim EY; Roshanravan H; Nikolos F; Thomas C; Hagmann H; Benzing T; Dryer SE
Am J Physiol Renal Physiol; 2015 Jul; 309(2):F98-108. PubMed ID: 26017975
[TBL] [Abstract][Full Text] [Related]
11. CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutation.
Cara-Fuentes G; Araya C; Wei C; Rivard C; Ishimoto T; Reiser J; Johnson RJ; Garin EH
Nefrologia; 2013; 33(5):727-31. PubMed ID: 24089165
[TBL] [Abstract][Full Text] [Related]
12. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
[TBL] [Abstract][Full Text] [Related]
13. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
Krall P; Canales CP; Kairath P; Carmona-Mora P; Molina J; Carpio JD; Ruiz P; Mezzano SA; Li J; Wei C; Reiser J; Young JI; Walz K
PLoS One; 2010 Sep; 5(9):e12859. PubMed ID: 20877463
[TBL] [Abstract][Full Text] [Related]
14. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
[TBL] [Abstract][Full Text] [Related]
15. Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.
Yoo TH; Pedigo CE; Guzman J; Correa-Medina M; Wei C; Villarreal R; Mitrofanova A; Leclercq F; Faul C; Li J; Kretzler M; Nelson RG; Lehto M; Forsblom C; Groop PH; Reiser J; Burke GW; Fornoni A; Merscher S
J Am Soc Nephrol; 2015 Jan; 26(1):133-47. PubMed ID: 24925721
[TBL] [Abstract][Full Text] [Related]
16. Podocyte protease activated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events.
May CJ; Chesor M; Hunter SE; Hayes B; Barr R; Roberts T; Barrington FA; Farmer L; Ni L; Jackson M; Snethen H; Tavakolidakhrabadi N; Goldstone M; Gilbert R; Beesley M; Lennon R; Foster R; Coward R; Welsh GI; Saleem MA
Kidney Int; 2023 Aug; 104(2):265-278. PubMed ID: 36940798
[TBL] [Abstract][Full Text] [Related]
17. Direct effect of plasma permeability factors from patients with idiopatic FSGS on nephrin and podocin expression in human podocytes.
Doublier S; Musante L; Lupia E; Candiano G; Spatola T; Caridi G; Zennaro C; Carraro M; Ghiggeri GM; Camussi G
Int J Mol Med; 2005 Jul; 16(1):49-58. PubMed ID: 15942677
[TBL] [Abstract][Full Text] [Related]
18. ATP acting through P2Y receptors causes activation of podocyte TRPC6 channels: role of podocin and reactive oxygen species.
Roshanravan H; Dryer SE
Am J Physiol Renal Physiol; 2014 May; 306(9):F1088-97. PubMed ID: 24553432
[TBL] [Abstract][Full Text] [Related]
19. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
Agrawal V; Prasad N; Jain M; Pandey R
Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
[TBL] [Abstract][Full Text] [Related]
20. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.
Wei C; El Hindi S; Li J; Fornoni A; Goes N; Sageshima J; Maiguel D; Karumanchi SA; Yap HK; Saleem M; Zhang Q; Nikolic B; Chaudhuri A; Daftarian P; Salido E; Torres A; Salifu M; Sarwal MM; Schaefer F; Morath C; Schwenger V; Zeier M; Gupta V; Roth D; Rastaldi MP; Burke G; Ruiz P; Reiser J
Nat Med; 2011 Jul; 17(8):952-60. PubMed ID: 21804539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
